🇺🇸 FDA
Pipeline program

paclitaxel/anthracycline

D09050703570904

Phase 3 small_molecule active

Quick answer

paclitaxel/anthracycline for Primary Breast Cancer is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Primary Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials